Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rufinamide
100%
Lennox-Gastaut Syndrome
100%
Seizure Frequency
33%
Anticonvulsant Therapy
33%
Placebo
16%
Beneficial Effects
16%
PubMed
16%
Clinical Response
16%
Epileptic Encephalopathy
16%
Vomiting
16%
Adjunctive Therapy
16%
Systematic Literature Review
16%
Adverse Effects
16%
Early childhood
16%
Somnolence
16%
4-year-olds
16%
Response Potential
16%
Epilepsy Syndrome
16%
Response Profiles
16%
Total Seizures
16%
Intractable childhood Epilepsy
16%
Well Tolerated
16%
Common Side Effects
16%
Tonic Seizures
16%
Safe Medication
16%
Atonic Seizures
16%
Optimal Effectiveness
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rufinamide
100%
Lennox Gastaut Syndrome
100%
Anticonvulsant Medication
33%
Placebo
16%
Epilepsy
16%
Brain Disease
16%
Syndrome
16%
Somnolence
16%
Tonic Seizure
16%
Benign Childhood Epilepsy
16%
Atonic Seizure
16%
Side Effect
16%
Adverse Effect
16%
Neuroscience
Lennox-Gastaut Syndrome
100%
Anticonvulsant
40%
Placebo
20%
Adjuvant Therapy
20%
Somnolence
20%
Pediatric Epilepsy
20%
Brain Disease
20%
Side Effect
20%
Epilepsy
20%
Adverse Effect
20%